GLP1 receptor agonist and SGLT2 inhibitor combination: An effective approach in real-life clinical practice.
Sign Up to like & getrecommendations! Published in 2020 at "Clinical therapeutics"
DOI: 10.1016/j.clinthera.2019.12.012
Abstract: PURPOSE The aim of this study was to evaluate the effectiveness and safety of combination therapy with a sodium-glucose cotransporter-2 (SGLT2) inhibitor and a glucagon-like peptide-1 receptor agonist (GLP1RA) in patients with inadequately controlled type… read more here.
Keywords: receptor agonist; combination; inhibitor combination; sglt2 inhibitor ... See more keywords
PD1 inhibitor in combination with 5-azacytidine and low-dose DLI for the successful treatment of AML patients who relapsed after transplantation
Sign Up to like & getrecommendations! Published in 2020 at "Bone Marrow Transplantation"
DOI: 10.1038/s41409-020-01130-8
Abstract: Acute myeloid leukaemia (AML) patients who relapse after allogeneic haematopoietic stem cell transplantation (allo-HSCT) have a poor prognosis. The management of AML relapse after allo-HSCT remains a major therapeutic challenge. Here, to the best of… read more here.
Keywords: inhibitor combination; pd1 inhibitor; successful treatment; aml patients ... See more keywords
Efficacy of a PARP inhibitor combination
Sign Up to like & getrecommendations! Published in 2018 at "Nature Reviews Urology"
DOI: 10.1038/s41585-018-0048-3
Abstract: A randomized phase II trial reports the clinical efficacy of poly(ADPribose) polymerase (PARP) inhibitor olaparib combined with abiraterone in metastatic castrationresistant prostate cancer. At a cutoff date in September 2017, median radiographic progressionfree survival was… read more here.
Keywords: inhibitor combination; parp inhibitor; efficacy parp; efficacy ... See more keywords
SGLT2 inhibitor plus DPP‐4 inhibitor as combination therapy for type 2 diabetes: A systematic review and meta‐analysis
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes"
DOI: 10.1111/dom.13294
Abstract: To assess the efficacy and safety of sodium‐glucose co‐transporter 2 (SGLT2) inhibitors plus a dipeptidyl peptidase‐4 (DPP‐4) inhibitor in patients with type 2 diabetes mellitus (T2DM), we performed a systematic review and meta‐analysis of 14… read more here.
Keywords: sglt2 inhibitor; dpp inhibitor; inhibitor combination; inhibitor ... See more keywords